SCHEMBL13720692

SCHEMBL13720692

Cc1ccc(C)c(Oc2ccc(NC(=O)[C@@H](C)N(C(=O)O)C(C)(C)C)cn2)c1.Cc1ccc(C)c(Oc2ccc(NC(=O)[C@@H](C)N)cn2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
HTR2C P28335 4/20 0.36
KMT2A Q03164 4/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 2/20 0.35
XIAP P98170 1/20 0.35
GFER P55789 1/20 0.35
MEN1 O00255 3/20 0.34
HTR2B P41595 3/20 0.34
CYP2C9 P11712 2/20 0.34
TTR P02766 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C8 P10632 1/20 0.34
CHRM1 P11229 1/20 0.34
TSHR P16473 1/20 0.34
ADRA1A P35348 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13721340 0.95 ALDH1A1 (0.40) ALDH1A1LMNAHTR2CKMT2APOLB
SCHEMBL1980785 0.88 ALDH1A1 (0.45) ALDH1A1LMNAHTR2CKMT2APOLB
SCHEMBL13720643 0.86 KEAP1 (0.43) ALDH1A1LMNAHTR2CKMT2APOLB
SCHEMBL13720861 0.85 HTR2C (0.41) ALDH1A1LMNAHTR2CKMT2APOLB
SCHEMBL20567346 0.85 HTR2C (0.41) ALDH1A1LMNAHTR2CKMT2APOLB
SCHEMBL21980921 0.82 KMT2A (0.41) ALDH1A1LMNAKMT2APOLBRAB9A
SCHEMBL13720786 0.82 KMT2A (0.41) ALDH1A1LMNAKMT2APOLBRAB9A
SCHEMBL13721319 0.81 KEAP1 (0.45) ALDH1A1LMNAHTR2CKMT2APOLB
SCHEMBL17350075 0.80 JAK2 (0.42) ALDH1A1LMNAHTR2CKMT2APOLB
SCHEMBL13721813 0.80 GAA (0.42) ALDH1A1KMT2APOLBRAB9AXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160058737-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2016-03-03 US disclosed
US-8722695-B2 Imidazolidinedione derivatives AUTIFONY THERAPEUTICS LIMITED (GB) 2014-05-13 US disclosed
US-20120289526-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160058737-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 ALDH1A1 848/4885LMNA 2187/4885HTR2C 334/4885
US-20120289526-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 ALDH1A1 462/4885LMNA 2517/4885HTR2C 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.